Company: PETVW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001493152-25-011967
Chunk: 31

Company: PetVivo Holdings, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 31
---
    Cancelled 
     -  
     -  

    Balance at June 30, 2025 
     112,500  
    $0.57  
    $90,000 

    (1)
    The
    aggregate intrinsic value of restricted stock units outstanding was based on the Company’s closing stock price on the last trading day of the
    period.

Stock
Options

Stock options issued to employees and directors typically vest over three
years (one
year for directors) and have a contractual
term of three 3  to seven
years. Stock-based compensation expense for stock options was $8,264 and
$173,325 for the three months ended June 30, 2025, and 2024, respectively. As of June 30, 2025, there were no unrecognized
stock option expense.

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model.
Annually, the Company makes predictive assumptions regarding future stock price volatility, dividend yield, expected term, and forfeiture
rate. The dividend yield assumption is based on expected annual dividend yield on a grant date. To date, no dividends on common stock
have been paid by the Company. Expected volatility for grants is based on historical volatility over a similar period as the expected
term. The risk-free interest rate is based on yields of U.S. Treasury securities with maturities similar to the expected term of the
options for each option group. The Company uses the “simplified method” to estimate the expected term of the stock option
grants. This approach is used because the Company does not have sufficient historical exercise data to develop a reasonable estimate of
expected term.

No
stock options were granted during the three months ended June 30, 2025. The Company recognized stock-based compensation expense in the
current period related to options granted in prior years. The following table summarizes the weighted-average assumptions used in estimating
the fair value of stock options granted during the year-ended March 31, 2025.the most recent period in which awards were issued:

 SCHEDULE OF ESTIMATED FAIR VALUE ASSUMPTION

    Year Ended 

    March
    31,2025 
  
    Expected term
     
     3
                                            years 
  
    Expected volatility
     
     135.6%
  
    Risk-free interest rate
     
     4.07%
  
    Expected dividend